Report of Foreign Issuer (6-k)
November 15 2018 - 7:20AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2018
Commission File Number: 001-36582
Auris Medical Holding AG
(Exact name of registrant as specified
in its charter)
Bahnhofstrasse 21
6300 Zug, Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
INCORPORATION
BY REFERENCE
Exhibits 99.1 and 99.2 to this
Report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form F-3 (Registration Number
333-228121) and the registration statement on Form S-8 (Registration Number 333-223855) of Auris Medical Holding AG and to be
a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently
filed or furnished.
Exhibit 99.3 to this Report on
Form 6-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange
Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933 or the Exchange Act.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
Auris Medical Holding AG
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Hernan Levett
|
|
|
|
|
|
Name:
|
Hernan Levett
|
|
|
|
|
|
Title:
|
Chief Financial Officer
|
|
Date: November 15,
2018
EXHIBIT
INDEX
Exhibit
Number
|
Description
|
99.1
|
Unaudited Condensed Consolidated Interim Financial Statements
|
99.2
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
99.3
|
Press Release dated November 15, 2018
|
|
|
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Sep 2023 to Sep 2024